Beyond NF-κB regulation, TAB1 mediates p38-mitogen-activated protein kinase (MAPK) activation via autophosphorylation, contributing to myocardial ischemia injury [47], while its knockdown mitigated cardiomyocyte hypertrophy [48]. The gene discussed is NFKB1; the disease is myocardial ischemia.